Cytosorbents Corp received a notice on October 2, 2025, indicating that its stock has been below $1.00 for 30 consecutive days, marking a non-compliance with Nasdaq rules, and has until March 31, 2026, to regain compliance. The company has a 180-day extension if necessary, to ensure its stock price meets the required bid price.